By using CITE-seq with antibodies against known ontogeny markers, Merad showed that certain subsets of dendritic cells affect how cancer patients respond to immunotherapy treatment 1. Several ...
Hosted on MSN15d
β-glucans show promise as adjuvants for allergy treatment6 glucan showed that these β-glucans increased the activation of the dendritic cells and upregulated the important surface markers CD40, CD80, CD86 and MHCII to varying degrees. Another finding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback